Haleon plc (NYSE:HLN) Shares Purchased by Choate Investment Advisors

Choate Investment Advisors boosted its stake in Haleon plc (NYSE:HLN) by 8.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,440 shares of the company’s stock after purchasing an additional 2,182 shares during the period. Choate Investment Advisors’ holdings in Haleon were worth $271,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Natixis Advisors LLC increased its holdings in Haleon by 3.6% in the 4th quarter. Natixis Advisors LLC now owns 1,527,392 shares of the company’s stock valued at $14,571,000 after purchasing an additional 53,625 shares in the last quarter. First Eagle Investment Management LLC boosted its position in Haleon by 4.7% in the 4th quarter. First Eagle Investment Management LLC now owns 2,104,289 shares of the company’s stock valued at $20,075,000 after buying an additional 93,553 shares during the last quarter. Atala Financial Inc purchased a new position in Haleon in the 4th quarter valued at about $104,000. EverSource Wealth Advisors LLC boosted its position in Haleon by 23.2% in the 4th quarter. EverSource Wealth Advisors LLC now owns 14,601 shares of the company’s stock valued at $139,000 after buying an additional 2,747 shares during the last quarter. Finally, Sequoia Financial Advisors LLC boosted its position in Haleon by 2.5% in the 4th quarter. Sequoia Financial Advisors LLC now owns 85,690 shares of the company’s stock valued at $814,000 after buying an additional 2,101 shares during the last quarter. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Haleon Stock Performance

Shares of HLN stock opened at $10.31 on Tuesday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. Haleon plc has a one year low of $7.89 and a one year high of $10.80. The company’s 50-day simple moving average is $9.77 and its 200-day simple moving average is $9.88. The stock has a market capitalization of $46.65 billion, a price-to-earnings ratio of 30.31, a PEG ratio of 2.82 and a beta of 0.25.

Haleon (NYSE:HLN) last issued its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The firm had revenue of $3.54 billion for the quarter, compared to analysts’ expectations of $3.38 billion. Equities analysts anticipate that Haleon plc will post 0.43 earnings per share for the current fiscal year.

Haleon Increases Dividend

The firm also recently announced a — dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be issued a $0.1166 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a yield of 1.6%. This is a boost from Haleon’s previous — dividend of $0.05. Haleon’s dividend payout ratio (DPR) is currently 58.97%.

Wall Street Analysts Forecast Growth

HLN has been the subject of a number of analyst reports. Hsbc Global Res cut shares of Haleon from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 5th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Haleon in a research report on Monday, March 3rd. HSBC reissued a “hold” rating on shares of Haleon in a research report on Wednesday, March 5th. Sanford C. Bernstein cut shares of Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Finally, Morgan Stanley cut shares of Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Six analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $10.95.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.